ABCB1 and cancer: Therefore, the administration of these NPs is intended to accompany dosages of other therapeutic elements: the siRNAs is targeted against P-glycoprotein mRNA, which acts as an efflux pump in cancer cells and participates in the clearance of the administered chemical compounds.